Stock·NYSE·Basic Materials
Ecolab Inc. (ECL)
- Market cap
- $84.93B
- P/E
- 41.22
- Dividend yield
- 0.96%
- Street target
- $330.00median of 24 analysts
- 52-week range
- $243.15 $309.27
ECL stock forecast today
Where ECL stands today, and what CleaRank Financial AI makes of it.
ECL at a glance
Ecolab Inc. (ECL): Buy, 67/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($281.96 and $275.95).
- Earnings ECL beat estimates in 3 of the 7 reports in our data, and the stock rose the next day every time.
- Insiders Insiders sold $31.2M and bought $4.1M over the last 18 months.
- Valuation P/E of 41.2 against 30.2 for the Basic Materials sector: a premium to peers (+37%).
Figures as of October 30, 2026.
CleaRank Financial AI
ECL, or Ecolab Inc., is rated Buy by CleaRank with a model score of 67/100.
Trend contributes the most to that score: the price sits 9.80% above its 200-day average and 7.45% above its 50-day average, and the 50-day average is 2.18% above the 200-day. Valuation is the largest drag. The P/E of 41.22 is 36.5% above the sector median (a premium to peers), and the P/S of 4.89 is 16.4% above the sector median. The 50-day average is $281.96 and the 200-day average is $275.95. The price rose 17.85% over the past year.
Only on CleaRank
Figures we compute ourselves from ECL's own price, earnings and insider-filing history. Tap one to see it in context.
ECL stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $302.98 is 7.5% above the 50-day simple moving average of $281.96.Price above its 200-day average ›
The price is 9.8% above the 200-day simple moving average of $275.95.50-day average above the 200-day ›
The 50-day average ($281.96) is 2.2% above the 200-day average ($275.95), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 90% of its 52-week range, between $243.15 and $309.27.
ECL share price
Pick a period: each tab shows how far ECL has moved over it, to the last close.
Today's trading
Where ECL sits inside today's range and its 52-week range.
ECL fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/5P/E above the sector median ›
The trailing P/E of 41.22 is 36.5% above the Basic Materials median of 30.2.P/S above the sector median ›
The price-to-sales ratio of 4.89 is 16.4% above the sector median of 4.2.Profitable over the last 12 months ›
Net income over the last 12 months was $2.1B on revenue of $17.4B, a net margin of 12.0%.Missed estimates in most recent reports ›
ECL beat the EPS estimate in 3 of the 7 reports in our data.Pays a dividend ›
The trailing dividend yield is 0.96%, or $2.92 a share a year.
Key statistics
The headline figures for ECL.
As of October 30, 2026, ECL trades at $302.98, with a market value of $84.93B, a P/E ratio of 41.22 and a dividend yield of 0.96%.
What the numbers say
CleaRank Financial AI's reading of ECL's valuation, growth and risks.
Ecolab Inc. (ECL) is priced at a premium. Its trailing P/E of 41.22 is 36.5% above the Basic Materials median of 30.2, and the peer comparison on this page rates it as a premium to peers. To put the size in context, the company has a market capitalisation of $84.9B and trailing earnings of $7.35 a share.
Its return on equity of 20.77% is above the sector median of 17.9%. On the balance sheet, debt-to-equity stands at 1.32, and the trailing dividend yield is 0.96%, or $2.92 a share per year.
EPS of $2.18 versus the $2.17 analysts expected made the October 27, 2026 report a beat of 0.46%. The market agreed: the stock rose 0.39% the following session.
Over the 7 reports in our data, ECL topped the estimate 3 times, and every one of those beats was followed by a gain the next day. Earlier, the stock fell 4.03% after the October 28, 2025 report, in line with the estimate. Looking ahead, analysts expect EPS of $8.16 this fiscal year (growth of 8.4%) and $9.38 the year after (growth of 14.9%).
The P/E of 41.22, 36.5% above the sector median, puts ECL at a premium to peers, so weaker results would meet a higher bar. On a typical day the price of ECL shifts by 1.05%, the 30-day standard deviation of its daily returns with a beta of 0.88 against the S&P 500. Insiders sold $31.2M over the last 18 months and bought $4.1M, though sales of this kind are often planned in advance and say less than purchases would.
ECL against the Basic Materials sector
How ECL compares with the median Basic Materials stock CleaRank tracks.
Price to earnings vs sector: ECL trades at a significant premium to sector peers (+37%), suggesting market expectations for superior growth or market position.
Return vs XLB: Since May 20, 2025, ECL has gained 15.5% against a gain of 21.1% for XLB.
Performance against XLB
ECL and the Basic Materials sector fund over the same days.
Revenue and earnings
How much ECL sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); ECL reported again on October 27, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 2.2% in FY2025 to $16.1B, from $15.7B a year earlier.
Profit margin: The net margin was 13.0% in FY2025, down from 13.5% the year before.
Profitable: ECL earned $2.1B in FY2025.
Earnings reality check
Did ECL beat what analysts expected, and how did the stock react?
Earnings record: ECL beat the analyst estimate in 3 of the 7 reports in our data.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 27, 2026after close | $2.17 | $2.18 | +0.46% | +0.39% | - |
| Apr 28, 2026after close | $1.70 | $1.70 | +0.00% | -3.88% | -3.49% |
| Feb 10, 2026after close | $2.07 | $2.08 | +0.48% | +1.31% | +0.99% |
| Oct 28, 2025after close | $2.07 | $2.07 | +0.00% | -4.03% | -3.59% |
| Jul 29, 2025after close | $1.90 | $1.89 | -0.53% | +1.44% | +2.73% |
| Apr 29, 2025after close | $1.50 | $1.50 | +0.00% | +1.83% | +2.32% |
| Feb 11, 2025after close | $1.80 | $1.81 | +0.56% | +0.31% | +1.92% |
As of October 30, 2026, ECL has beaten the analyst EPS estimate in 3 of the 7 reports in our data and rose in the first trading session after every one of those beats; its latest report, on October 27, 2026, came in 0.46% above the estimate and the stock moved +0.39% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
ECL AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI overbought or oversold ›
The 14-day RSI is 73.1, in overbought territory.RSI above 50 ›
An RSI of 73.1 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of ECL
The score, the reasoning behind it, and what could move the price next.
Ecolab Inc. (ECL) is trending up. The price of $302.98 sits 7.45% above its 50-day average of $281.96 and 9.80% above its 200-day average of $275.95. It is also near the top of its 52-week range: 2.03% below the high of $309.27, and 24.61% above the low of $243.15.
The 14-day RSI of 73.1 is in overbought territory, and the MACD line is positive. The recent returns are all positive: the price rose 9.13% over the past three months, rose 16.75% over the past six months and rose 17.85% over the past year.
Earnings beat ›
The October 27, 2026 report beat the EPS estimate by 0.46%, and the share price rose 0.39% in the first session after it.
Source: Earnings report, October 27, 2026Analyst upgrade ›
Oppenheimer upgraded it to Outperform from Perform on July 17, 2026.
Source: Analyst action, Oppenheimer, July 17, 2026Rating reaffirmed ›
UBS kept its Buy rating on October 5, 2026.
Source: Analyst action, UBS, October 5, 2026
- For Ecolab Inc. (ECL), the two closest levels are the 52-week high of $309.27 above the price and the 20-day EMA of $288.99 below it.
- A 14-day RSI of 73.1 places ECL in the overbought zone, and the MACD line is positive. Readings above 70 or below 30 point to stretched momentum.
- Ecolab Inc. (ECL) rose 0.39% in the first session after its October 27, 2026 report. Across the 7 reports in our data, it beat estimates in 3 of them.
The uptrend rests on ECL staying above its 50-day average at $281.96 and its 200-day average at $275.95; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $288.99.
Ecolab Inc. (ECL) has its next level overhead at the 52-week high of $309.27.
Technical indicators
Momentum and trend for ECL, from its daily closes.
As of October 30, 2026, with ECL at $302.98, its 14-day RSI is 73.1 (overbought territory), its 50-day simple moving average is $281.96 and its 200-day is $275.95.
Calculated by CleaRank on daily closes as of October 30, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What ECL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 30, 2026, ECL's 1-year correlation of daily returns is +0.43 with S&P 500 (SPY), +0.27 with Nasdaq 100 (QQQ), +0.02 with Bitcoin (BTC) and +0.12 with gold (XAU).
ECL price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
20 of 24 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $330.00 is 8.9% above the price.More buy ratings than three months ago ›
20 of 24 rate it a buy now, against 20 of 26 three months ago.
ECL Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 5, 2026 | UBS | Maintains | Buy |
| Jul 30, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Jul 29, 2026 | Mizuho | Maintains | Outperform |
| Jul 29, 2026 | BMO Capital | Maintains | Outperform |
| Jul 29, 2026 | JP Morgan | Maintains | Overweight |
| Jul 17, 2026 | Oppenheimer | Upgrade | Outperform |
As of October 30, 2026, 24 Wall Street analysts cover ECL: 20 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $295.00 to $360.00. The median ECL price target is $330.00, 8.9% above the price of $302.98.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ECL trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ECL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from ECL's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ECL tends to move, against the market and on its own.
ECL price history and drawdowns
ECL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.05% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 40.3%, from December 2021 to November 2022, regained by March 2024.Most 1-year holds ended higher ›
81% of 1-year holding periods in the last 10 years ended with a gain.Trailed the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $29,553, against $41,607 in the S&P 500 (SPY).
ECL Drawdowns & Recovery
As of October 30, 2026, ECL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -40.3% (December 2021 to November 2022); it regained that peak by March 2024, 16 months after the low, and 81% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ECL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: ECL trailed the S&P 500 over this period: $29,553 against $41,607.
A $10,000 investment in ECL in October 2016 would be worth about $29,553 today with dividends reinvested, compared with about $41,607 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ECL, and which have not.
Strongest month, November: an average of +3.46%, up in 7 of 10 years.
Weakest month, September: an average of -2.25%, up in 3 of 10 years.
This month, October: has averaged -0.64%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, ECL's strongest calendar month has been November (average +3.46%, up in 7 of 10 years) and its weakest September (average -2.25%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
ECL stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ECL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in ECL today could grow to about $13,523 by 2030 in the base case, with a 90th-percentile outcome near $25,755 and a 10th-percentile outcome around $7,100. The simulation models price only; at today's 0.96% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
ECL Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $410 for ECL by 2030 in the base case, from $303 today (1.4x over 4 years). The 10th-percentile path ends near $215. These are outcomes of a Monte Carlo simulation run on ECL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $237 | $327 | $451 | |
| 2028 | $223 | $352 | $556 | |
| 2029 | $217 | $380 | $664 | |
| 2030 | $215 | $410 | $780 |
Method: a lognormal simulation of ECL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
ECL insider trading
What the people running the company have bought and sold.
ECL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $4.1M on the open market and sold $31.2M.
As of October 30, 2026, ECL insiders reported 18 open-market sales worth $31.2M and 7 open-market purchases worth $4.1M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Eric Mark Green
Director
|
Buy | 3.7K | $1.0M |
| Aug 18, 2026 | Christophe Beck
Chief Executive Officer
|
Sell | 17.9K | $5.0M |
| Aug 11, 2026 | Gregory B Cook
Officer
|
Sell | 4.6K | $1.3M |
| Aug 3, 2026 | Jennifer J Bradway
Officer
|
Grant | 6.5K | - |
| Jul 30, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Sell | 3.4K | $929.8K |
| Jul 30, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Option | 4.0K | $467.6K |
| Jun 30, 2026 | Judson Althoff
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Shari L Ballard
Director
|
Grant | 260 | $36.3K |
| Jun 30, 2026 | Michel Doukeris
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Eric Mark Green
Director
|
Grant | 273 | $40.0K |
| Jun 30, 2026 | Marion K Gross
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Michael J Larson
Director
|
Grant | 130 | - |
| Jun 30, 2026 | David W Maclennan
Director
|
Grant | 176 | $12.8K |
| Jun 30, 2026 | Tracy B. Mckibben
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Lionel L Nowell III
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Suzanne M. Vautrinot
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Julie Patenaude Whalen
Director
|
Grant | 130 | - |
| Jun 30, 2026 | John J Zillmer
Director
|
Grant | 130 | - |
| Jun 11, 2026 | Benjamin M. Clark
Officer
|
Buy | 1.0K | $263.8K |
| Jun 10, 2026 | Michel Doukeris
Director
|
Buy | 7.8K | $2.0M |
| Jun 9, 2026 | Darrell R Brown
Officer
|
Sell | 10.0K | $2.6M |
| Jun 9, 2026 | Darrell R Brown
Officer
|
Option | 10.0K | $1.2M |
| May 27, 2026 | Suzanne M. Vautrinot
Director
|
Sell | 1.0K | $266.0K |
| May 22, 2026 | Suzanne M. Vautrinot
Director
|
Option | 2.0K | $251.3K |
| May 13, 2026 | David W Maclennan
Director
|
Buy | 1.0K | $250.7K |
| May 4, 2026 | Gregory B Cook
Officer
|
Grant | 8.4K | - |
| May 4, 2026 | David W Maclennan
Director
|
Buy | 800 | $205.5K |
| Mar 31, 2026 | Judson Althoff
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Shari L Ballard
Director
|
Grant | 275 | $36.2K |
| Mar 31, 2026 | Michel Doukeris
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Eric Mark Green
Director
|
Grant | 289 | $40.0K |
| Mar 31, 2026 | Marion K Gross
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Michael J Larson
Director
|
Grant | 137 | - |
| Mar 31, 2026 | David W Maclennan
Director
|
Grant | 186 | $12.8K |
| Mar 31, 2026 | Tracy B. Mckibben
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Lionel L Nowell III
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Victoria J Reich
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Suzanne M. Vautrinot
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Julie Patenaude Whalen
Director
|
Grant | 137 | - |
| Mar 31, 2026 | John J Zillmer
Director
|
Grant | 137 | - |
| Mar 27, 2026 | Michael J Larson
Director
|
Option | 2.3K | $264.7K |
| Feb 26, 2026 | Gregory B Cook
Officer
|
Sell | 3.5K | $1.1M |
| Feb 26, 2026 | Gregory B Cook
Officer
|
Option | 3.8K | $520.9K |
| Feb 25, 2026 | Tracy B. Mckibben
Director
|
Sell | 1.3K | $390.5K |
| Feb 25, 2026 | Margeaux King
Officer
|
Grant | 1.7K | - |
| Feb 25, 2026 | Tracy B. Mckibben
Director
|
Option | 2.3K | $264.7K |
| Feb 24, 2026 | Christophe Beck
Chief Executive Officer
|
Sell | 20.0K | $6.1M |
| Feb 24, 2026 | Christophe Beck
Chief Executive Officer
|
Option | 23.8K | $2.8M |
| Feb 24, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Grant | 404 | - |
| Feb 18, 2026 | Nicholas J Alfano
Officer
|
Grant | 2.2K | - |
| Feb 18, 2026 | Christophe Beck
Chief Executive Officer
|
Grant | 25.4K | - |
| Feb 18, 2026 | Jandeen M Boone
General Counsel
|
Grant | 593 | - |
| Feb 18, 2026 | Jennifer J Bradway
Officer
|
Grant | 1.9K | - |
| Feb 18, 2026 | Darrell R Brown
President
|
Grant | 8.5K | - |
| Feb 18, 2026 | Gregory B Cook
Officer
|
Grant | 3.4K | - |
| Feb 18, 2026 | Boo Alexander A De
Officer
|
Grant | 2.4K | - |
| Feb 18, 2026 | Alexandra M A Hlila
Officer
|
Grant | 508 | - |
| Feb 18, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Grant | 9.7K | - |
| Feb 17, 2026 | Nicholas J Alfano
Officer
|
Sell | 9.5K | $2.9M |
| Feb 17, 2026 | Nicholas J Alfano
Officer
|
Option | 9.5K | $1.3M |
| Feb 13, 2026 | Victoria J Reich
Director
|
Sell | 1.0K | $301.1K |
| Feb 13, 2026 | Jennifer J Bradway
Officer
|
Sell | 613 | $185.1K |
| Feb 13, 2026 | Jennifer J Bradway
Officer
|
Option | 950 | $130.2K |
| Feb 13, 2026 | Victoria J Reich
Director
|
Option | 1.0K | $115.1K |
| Feb 13, 2026 | John J Zillmer
Director
|
Option | 2.3K | $264.7K |
| Dec 31, 2025 | Judson Althoff
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Shari L Ballard
Director
|
Grant | 256 | $33.8K |
| Dec 31, 2025 | Michel Doukeris
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Eric Mark Green
Director
|
Grant | 265 | $36.3K |
| Dec 31, 2025 | Marion K Gross
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Michael J Larson
Director
|
Grant | 128 | - |
| Dec 31, 2025 | David W Maclennan
Director
|
Grant | 171 | $11.6K |
| Dec 31, 2025 | Tracy B. Mckibben
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Lionel L Nowell III
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Victoria J Reich
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Suzanne M. Vautrinot
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Julie Patenaude Whalen
Director
|
Grant | 128 | - |
| Dec 31, 2025 | John J Zillmer
Director
|
Grant | 128 | - |
| Dec 8, 2025 | David W Maclennan
Director
|
Buy | 750 | $193.2K |
| Dec 4, 2025 | Harpreet Saluja
Officer
|
Grant | 1.3K | - |
| Nov 24, 2025 | Boo Alexander A De
Officer
|
Sell | 1.4K | $381.5K |
| Nov 24, 2025 | Boo Alexander A De
Officer
|
Option | 2.2K | $256.5K |
| Nov 12, 2025 | Christophe Beck
Chief Executive Officer
|
Sell | 21.7K | $5.7M |
| Nov 12, 2025 | Christophe Beck
Chief Executive Officer
|
Option | 23.1K | $2.7M |
| Nov 12, 2025 | David W Maclennan
Director
|
Option | 3.3K | $379.7K |
| Sep 30, 2025 | Judson Althoff
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Shari L Ballard
Director
|
Grant | 246 | $33.8K |
| Sep 30, 2025 | Michel Doukeris
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Eric Mark Green
Director
|
Grant | 255 | $36.3K |
| Sep 30, 2025 | Marion K Gross
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Michael J Larson
Director
|
Grant | 123 | - |
| Sep 30, 2025 | David W Maclennan
Director
|
Grant | 165 | $11.6K |
| Sep 30, 2025 | Tracy B. Mckibben
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Lionel L Nowell III
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Victoria J Reich
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Suzanne M. Vautrinot
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Julie Patenaude Whalen
Director
|
Grant | 75 | - |
| Sep 30, 2025 | John J Zillmer
Director
|
Grant | 123 | - |
| Aug 19, 2025 | Suzanne M. Vautrinot
Director
|
Sell | 1.4K | $383.4K |
| Aug 14, 2025 | Suzanne M. Vautrinot
Director
|
Option | 2.3K | $264.7K |
| Aug 13, 2025 | Jennifer J Bradway
Officer
|
Sell | 807 | $225.4K |
| Aug 13, 2025 | Jennifer J Bradway
Officer
|
Option | 993 | $116.9K |
| Aug 13, 2025 | David W Maclennan
Director
|
Buy | 600 | $167.1K |
| Jun 30, 2025 | Judson Althoff
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Shari L Ballard
Director
|
Grant | 252 | $33.8K |
| Jun 30, 2025 | Michel Doukeris
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Marion K Gross
Director
|
Grant | 76 | - |
| Jun 30, 2025 | Michael J Larson
Director
|
Grant | 126 | - |
| Jun 30, 2025 | David W Maclennan
Director
|
Grant | 169 | $11.6K |
| Jun 30, 2025 | Tracy B. Mckibben
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Lionel L Nowell III
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Victoria J Reich
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Suzanne M. Vautrinot
Director
|
Grant | 126 | - |
| Jun 30, 2025 | John J Zillmer
Director
|
Grant | 126 | - |
| Jun 12, 2025 | Victoria J Reich
Director
|
Sell | 1.3K | $352.3K |
| Jun 12, 2025 | Victoria J Reich
Director
|
Option | 1.3K | $149.6K |
| May 19, 2025 | Gregory B Cook
Officer
|
Grant | 65 | - |
| May 15, 2025 | Gregory B Cook
Officer
|
Sell | 2.2K | $565.2K |
| May 15, 2025 | Gregory B Cook
Officer
|
Option | 2.2K | $263.0K |
| May 7, 2025 | Nicholas J Alfano
Officer
|
Sell | 9.9K | $2.5M |
Source: TwelveData, from SEC Form 4 filings
ECL stock forecast: questions people ask
Answered from the figures on this page, as of October 30, 2026.